Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Advanced Chronic Kidney Disease

Discussion. OFXais were better tolerated compared to warfarin for the treatment of VTE in CKD, with lower rates of bleeding, discontinuations, and recurrent thromboembolism in a small cohort. Future prospective studies are necessary to confirm these findings.PMID:33628255 | PMC:PMC7895609 | DOI:10.1155/2021/8870015

Source: Advances in Hematology - February 25, 2021 Category: Hematology Authors: Tania Ahuja Kelly Sessa Cristian Merchan John Papadopoulos David Green Source Type: research